GBBYF yields 5.25% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, GBBYF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GBBYF + JNJ for your $10,000?
Goodbaby International Holdings Limited, an investment holding company, researches, designs, develops, manufactures, markets, and sells durable juvenile products in Europe, North America, Mainland China, and internationally. The company operates through four segments: Strollers and Accessories, Car Seats and Accessories, Non-Durable Products, and Others. It offers children's car safety seats, strollers, apparels and home textile products, feeding products, nursing and personal care products, cribs, bicycles and tricycles, and other children products. The company also provides safety belts, cloth sets, and car components for children; child cloth beds; bath chairs for children; stadium chairs; sports utilities, e-cars, and wooden products; and child carrying systems, pushchairs, high chairs, and other products for children, as well as maternity products. In addition, it offers IT services and a share service center; testing services for children's products, tools, and electronic products; and advisory services for the risk valuation of product quality. Further, the company is involved in the distribution and sale of car safety seats, infant strollers, and other parenting products; and wholesale and retail of children's products. It also operates flagship stores. The company provides its products under the Goodbaby, CYBEX, gb, Evenflo, RollPlay, CBX, Exer Saucer, Urbini, and Happy Dino brands. The company was founded in 1989 and is headquartered in Kunshan, the People's Republic of China.
Full GBBYF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.